{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:10:07Z","timestamp":1760062207011,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Aina Wallstr\u00f6m and Mary-Ann Sj\u00f6blom Foundation for Medical Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejso.2018.08.031","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T02:02:39Z","timestamp":1540000959000},"page":"225-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-8302","authenticated-orcid":false,"given":"Valerio","family":"Belgrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Katsarelias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2018.08.031_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.ejso.2018.08.031_bib2","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1245\/s10434-014-4349-3","article-title":"Tumor mitotic rate added to the equation: melanoma prognostic factors changed?: a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients","volume":"22","author":"Speijers","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5694\/mja15.00148","article-title":"Differing trends in thickness and survival between nodular and non-nodular primary cutaneous melanoma in Victoria, Australia","volume":"203","author":"Smithson","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejso.2018.08.031_bib4","first-page":"CD010307","article-title":"Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma","volume":"5","author":"Kyrgidis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejso.2018.08.031_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000658-199910000-00001","article-title":"Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group","volume":"230","author":"Morton","year":"1999","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.ejso.2018.08.031_bib6","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-011-1826-9","article-title":"Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database","volume":"18","author":"White","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.08.031_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.031_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejso.2016.08.007","article-title":"Sentinel node biopsy in melanoma: current controversies addressed","volume":"43","author":"Madu","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2018.08.031_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/02841860701785533","article-title":"Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005","volume":"47","author":"Mattsson","year":"2008","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/02844310500370282","article-title":"Sentinel node biopsy in cutaneous melanoma","volume":"40","author":"Lock-Andersen","year":"2006","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"issue":"10","key":"10.1016\/j.ejso.2018.08.031_bib11","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/cncr.22295","article-title":"Predicting sentinel node status in AJCC stage I\/II primary cutaneous melanoma","volume":"107","author":"Kruper","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.031_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejca.2005.10.023","article-title":"High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma","volume":"42","author":"van Akkooi","year":"2006","journal-title":"Eur J Canc"},{"issue":"27","key":"10.1016\/j.ejso.2018.08.031_bib13","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1200\/JCO.2006.06.3198","article-title":"Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival","volume":"24","author":"Cascinelli","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.031_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1245\/s10434-007-9684-1","article-title":"The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center","volume":"15","author":"Sassen","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.031_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1245\/ASO.2003.09.016","article-title":"Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients","volume":"10","author":"Rousseau","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.08.031_bib16","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-008-0273-8","article-title":"Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI)","volume":"16","author":"Testori","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.08.031_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1054\/bjps.2002.3825","article-title":"The learning curve for sentinel node biopsy in malignant melanoma","volume":"55","author":"Ross","year":"2002","journal-title":"Br J Plast Surg"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.031_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.08.031_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","article-title":"A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system","volume":"12","author":"Wong","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.22382","article-title":"The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma","volume":"109","author":"Paek","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"van der Ploeg","year":"2014","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib22","first-page":"301","article-title":"Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma","volume":"35","author":"Kim","year":"2015","journal-title":"Anticancer Res"},{"issue":"13","key":"10.1016\/j.ejso.2018.08.031_bib23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.ejca.2010.06.003","article-title":"EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria","volume":"46","author":"van der Ploeg","year":"2010","journal-title":"Eur J Canc"},{"issue":"10","key":"10.1016\/j.ejso.2018.08.031_bib24","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"van Akkooi","year":"2006","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2018.08.031_bib25","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1245\/s10434-018-6647-7","article-title":"Prediction of residual nodal disease at completion dissection following positive sentinel lymph node biopsy for melanoma","volume":"25","author":"Sinnamon","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.031_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CMR.0b013e328343ecf4","article-title":"Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma","volume":"21","author":"Fink","year":"2011","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.031_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1346-8138.2011.01318.x","article-title":"Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan","volume":"39","author":"Namikawa","year":"2012","journal-title":"J Dermatol"},{"issue":"12","key":"10.1016\/j.ejso.2018.08.031_bib28","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1245\/s10434-010-1142-9","article-title":"Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden","volume":"17","author":"Rutkowski","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"36","key":"10.1016\/j.ejso.2018.08.031_bib29","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2018.08.031_bib30","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"16","key":"10.1016\/j.ejso.2018.08.031_bib31","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.ejca.2009.08.015","article-title":"Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden","volume":"45","author":"van Akkooi","year":"2009","journal-title":"Eur J Canc"},{"issue":"23","key":"10.1016\/j.ejso.2018.08.031_bib32","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.031_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrclinonc.2014.64","article-title":"Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention","volume":"11","author":"van Akkooi","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.031_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2018.08.031_bib35","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ejso.2018.08.031_bib36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.031_bib37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2009.25.7428","article-title":"Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma","volume":"28","author":"Voit","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.031_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bjs.10040","article-title":"Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer","volume":"103","author":"Motomura","year":"2016","journal-title":"Br J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318314197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318314197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:29:43Z","timestamp":1760059783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318314197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0748798318314197"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.08.031","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}